| Labatec Pharma SA - Ondansetron ODT Labatec 8 mg, comprimés orodispersibles | | 63263 | | 02 | | Ondansetron ODT Labatec 8 mg | | comprimés orodispersibles | | A04AA01 | | Ondansetron | | 27.08.2014 | | |
| | Composition | | ondansetronum 8 mg, mannitolum, sorbitolum 6.03-16.884 mg, crospovidonum, silica colloidalis anhydrica, cellulosum microcristallinum, crospovidonum, natrii stearylis fumaras corresp. natrium 0.2 mg, magnesii stearas, aromatica, aspartamum 1.76 mg pro compresso. | | Packungsbestandteile | | Melting tablets | | | | | Active Agent | Dose |
|---|
| Ondansetron | 8 mg |
| | BAG: Active Agent | Dose |
|---|
| Ondansetron | 8 mg |
| | | | Inactive agents | Dose |
|---|
| Aromatica | | | Aspartame | 1.76 mg | | Cellulosum Microcristallinum | | | Crospovidonum | | | Magnesii Stearas | | | Mannitol | | | Natrii Stearylis Fumaras | | | Pro Compresso | | | Silica Colloidalis Anhydrica | | | Sorbitol | 6.03-16.884 mg |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 6 Tablet(s) | 22.61 | 40.95 | B | SL | Yes | | 004 | 10 Tablet(s) | PR | PR | B | | Yes |
|
|
